Search research articles
Contact Us
Filters
Showing results (491-500 of 664) with videos related to
Page
of 67
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group
Anja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Scientific Reports
|
August 4, 2025
Anticancer activity of triterpene glycosides from the sea star Solaster pacificus
Sergey A Dyshlovoy, Jessica Hauschild, Malte Kriegs, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
Tim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Anticancer Research
|
May 18, 2012
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma
Lisa Billecke, Eva Maria Murga Penas, Annette M May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Circulating tumor cells in patients with testicular germ cell tumors
Paulina Nastały, Christian Ruf, Pascal Becker, et al.
Oncoimmunology
|
August 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients
Joao Gorgulho, Timo Trenkner, Eva Kinkel, et al.
Annals of Hematology
|
June 16, 2026
Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis
Marie Harzer, Nils Gross-Fengels, Fede Melzer, et al.
BMC Cancer
|
February 2, 2017
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells
Sergey A Dyshlovoy, Ramin Madanchi, Jessica Hauschild, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
British Journal of Haematology
|
June 10, 2020
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
Walter Fiedler, Joerg Chromik, Stefanie Amberg, et al.
Page
of 67
Search research articles
Search
Showing results (491-500 of 664) with videos related to
Sort By:
Page
of 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group
Anja Lorch, Christian Kollmannsberger, Joerg Thomas Hartmann, et al.
Scientific Reports
|
August 4, 2025
Anticancer activity of triterpene glycosides from the sea star Solaster pacificus
Sergey A Dyshlovoy, Jessica Hauschild, Malte Kriegs, et al.
Cancer Immunology, Immunotherapy : CII
|
August 1, 2014
Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
Tim Luetkens, Sebastian Kobold, Yanran Cao, et al.
Anticancer Research
|
May 18, 2012
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma
Lisa Billecke, Eva Maria Murga Penas, Annette M May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 18, 2014
Circulating tumor cells in patients with testicular germ cell tumors
Paulina Nastały, Christian Ruf, Pascal Becker, et al.
Oncoimmunology
|
August 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients
Joao Gorgulho, Timo Trenkner, Eva Kinkel, et al.
Annals of Hematology
|
June 16, 2026
Characteristics, treatment regimens, and outcomes of patients with true extramedullary multiple myeloma: a real-world monocentric analysis
Marie Harzer, Nils Gross-Fengels, Fede Melzer, et al.
BMC Cancer
|
February 2, 2017
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells
Sergey A Dyshlovoy, Ramin Madanchi, Jessica Hauschild, et al.
Clinical & Developmental Immunology
|
December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantation
Sebastian Kobold, Sinje Tams, Tim Luetkens, et al.
British Journal of Haematology
|
June 10, 2020
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia
Walter Fiedler, Joerg Chromik, Stefanie Amberg, et al.
Page
of 67